Furthermore, in NSCLC cell lines, including NCI-H1703, A549, and NCI-H1299, pharmacological inhibition of NFAT2 or NFAT2 knockdown results in growth inhibition [43]. Here, NFATC1 is linked to non-small cell lung carcinoma.